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HIV+ candidates in need of organ transplantation face an increased risk of mortality while 
on the organ waitlist and decreased access to transplantation compared to HIV-uninfected (HIV-) 
candidates. Fortunately, HIV+ donor organs can now legally be transplanted into HIV+ recipients, 
thanks to the HIV Organ Policy Equity (HOPE) Act of 2013, which reverses an outdated ban and 
unlocks a pool of organs from an estimated 300-500 HIV+ deceased donors in the US annually. 
However, challenges in the current organ donation system and stigma against HIV present 
barriers to HOPE implementation and the potential for life-saving HIV+ donor to HIV+ recipient 
(HIV-to-HIV) organ transplantation. In collaboration with transplant surgeons, infectious 
disease healthcare providers, organ donation community consultants, and medical illustrators, a 
novel animation workflow was developed to create HOPE education materials. The animations, 
targeted to potential donors and recipients with HIV, healthcare providers, and professionals in 
the organ donation community are intended to promote  awareness and ultimately increase the 
rate of HIV-to-HIV transplantation. 
To efficiently communicate to these critical audiences, the animation process was 
streamlined by combining overlapping information into reusable components and addressing 
each audience with a customized call-to-action clip. The results of this project provide two 
individual animations addressed to (1) people living with HIV and (2) professionals in the organ 
donation community. The animations consist of reusable clips that explain the background 
information of the HOPE Act, the potential biological risks of HIV-to-HIV transplantation, and 
a concluding statement that reminds the viewer that their participation is essential to continue 
the success of the HOPE Act. Each animation concludes with an individualized call-to-action 
segment that inspires viewers to make a change. 
By informing these critical audiences through inclusive and educational animations, this 
project aims to reduce stigma in HIV+ organ donor referrals and registration and to encourage 
participation in HIV-to-HIV transplantation.
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Introduction
HIV (Human Immunodeficiency Virus) is an RNA retrovirus that damages a person’s 
immune system by leading to reductions in CD4+ immune cells. If not treated, an HIV 
infection can progress to Acquired Immunodeficiency Syndrome, or AIDS. During the acquired 
immunodeficiency syndrome (AIDS) epidemic in the 1980s, there was no effective treatment 
for HIV, which spreads through contact with specific body fluids, including blood products. In 
addition, HIV diagnoses were unreliable (Doby et al. 2018). As a result, acquiring organs for 
transplantation from those who were known or suspected to be living with HIV was banned as 
a protective measure (Doby et al. 2018). Fortunately, the life expectancy of people living with 
HIV has improved dramatically with advancements in antiretroviral therapy (ART), which has 
changed HIV from a fatal disease to a controllable, chronic condition (Boyarsky et al. 2015). 
Today, someone with HIV whose virus stays suppressed with continuous ART can live a long, 
healthy life and has effectively no risk of transmitting HIV. 
Despite reductions in the number of AIDS-related deaths due to widespread use of effective 
ART,  other complications such as end-stage renal disease and end-stage liver disease have 
increased proportionally as people with controlled HIV live longer (Durand et al. 2016). End-
stage organ diseases often surpass opportunistic infections seen in advanced stages of HIV 
infection, and liver and kidney failure have become more prevalent causes of mortality in 
individuals with HIV (Campos et al. 2016). As a result, people living with HIV are increasingly 
in need of organ transplantation (Bansal et al. 2018). 
Studies have demonstrated that patients with HIV who also have end-stage organ 
disease can receive organ transplants from donors without HIV, with outcomes comparable to 
those of HIV- transplant recipients (Durand et al. 2016). However, limited organ availability 
prevents transplant candidates with HIV from receiving an organ transplant (Bansal et al. 
2018). Furthermore, patients with HIV in need of an organ transplant face decreased access to 
transplantation and a disproportionately higher risk of mortality while on the waitlist compared 
to candidates without HIV (Durand et al. 2016). Many patients living with HIV die each year 
while waiting for a lifesaving organ transplant  (Boyarsky et al. 2015). 
2
The HOPE Act 
Successful organ transplantation from HIV+ donors to HIV+ recipients (HIV-to-HIV 
transplantation) has been encouraging in South Africa, where access to dialysis is limited, 
and HIV+ deceased donors provided a novel organ supply to support the greater need for 
transplants (Boyarsky et al. 2015). These cases demonstrated potential for adopting HIV-to-HIV 
transplantation practices in the United States (US) to combat the organ shortage. The HIV Organ 
Policy Equity (HOPE) Act, passed in 2013 reversed the outdated federal ban on the use of organs 
from HIV+ donors in transplantation and currently allows HIV-to-HIV transplantation under 
research protocols (Boyarsky et al. 2016). This important policy change unlocked a potential 
organ supply of an estimated 300-500 HIV+ deceased donors annually in the US and also allows 
people with HIV to become living organ donors (Segev 2019). Additionally, the HOPE Act has 
the potential of benefiting not only people living with HIV, but also HIV-uninfected individuals 
on the waitlist by expanding the donor pool overall. The policy changes introduced by the HOPE 
Act reflect the principle of equity: they expanded the organ donor pool to help those in need of 
an organ have more opportunities for a transplant, and they may even help to mitigate stigma 
associated with HIV (Durand et al. 2016). 
The HOPE in Action study is the first multicenter study in the US to follow outcomes of 
research-mandated HIV-to-HIV transplantation from both living and deceased HIV+ donors. 
However, since the enactment of the HOPE Act in 2013, there have only been two living HIV+ 
donors and  lower than expected numbers of deceased HIV+ donors. In contrast to the estimated 
potential of 300-500 HIV+ deceased donors per year, there were only 37 deceased HIV+ donors 
in 2019 (Figure 1). 
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Challenges and barriers to HOPE implementation 
Challenges in the current organ transplantation and donation system present potential 
barriers to the implementation of HOPE Act policy. 
HIV stigma in donor referrals and registration 
Unexpectedly low rates of HIV-to-HIV transplantation may be due to a lack of awareness in 
the public and incomplete implementation of the HOPE Act in the transplant system, as well as 
stigma against HIV in organ donor referrals and organ donor registration (Rasmussen et al. 2018). 
Prior to the HOPE Act in 2013, many people living with HIV did not register to become organ 
donors due to the ban on the use of organs from HIV+ donors in transplantation. In a survey 
taken at an HIV clinic in Baltimore, only 26% of participants were aware of the HOPE Act, and 
only 20% had registered to be organ donors (Nguyen et al. 2018). However, a surprising 62% of 
HIV+ participants were willing to become living organ donors, and 79% were willing to register 
Figure 1. Deceased HIV+ donors under the HOPE Act between 2016 and 2019. There were 9 donors 
in both 2016 and 2017, with an increase to 32 donors in 2018, and 37 donors in 2019 (Segev 2019). Still, 
these numbers are lower than the estimated potential of 300-500 donors per year, which is shown on the 
right for comparison.
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to become deceased donors (Nguyen et al. 2018). 
Additionally, it is federally mandated that nurses at hospitals with trauma centers refer 
critically ill patients to their local Organ Procurement Organization (OPO) for organ donation. 
OPOs serve two major roles in their geographical service  area: (1) They educate communities 
to encourage donor registration, and (2) When a patient is referred to an OPO by critical care 
hospitals, OPO representatives evaluate and screen potential donors, check the patient’s state 
donor registry, discuss donation with the patient’s families, obtain a candidate match list for 
that specific donor, and arrange for organ recovery and transport22. An unknown number 
of  hospital staff are operating under the incorrect assumption that patients with HIV are not 
suitable candidates for organ donation based solely on their HIV status, and due to this lack of 
donor hospital education, an unknown number of referrals are missed between the hospital and 
OPOs. Similarly, if HIV+ patients are referred to an OPO for screening, OPO representatives 
may also have a preconceived stigma against HIV and declare HIV+ patients unsuitable donation 
candidates for that reason.
Biological risks 
There are potential clinical risks related to HIV-to-HIV transplantation that could pose 
additional barriers to HOPE Act implementation (Boyarsky et al. 2015). One of the main 
biological risks related to transplantation of organs from HIV+ donors is HIV superinfection. 
HIV consists of a family of genetically different viruses, called strains. HIV superinfection can 
be defined as the transmission of at least one novel strain of the virus (not already present in the 
recipient) from a donor. Contracting multiple strains of HIV can occur with all modes of HIV 
transmission, including theoretically, receiving an organ from a donor with HIV (Smith et al. 
2005). Having more than one strain of HIV is only clinically relevant if that strain cannot be 
suppressed by the individual’s ART, or in other words, is drug-resistant to the particular ART 
regimen.  HIV is prone to developing drug-resistance due to the rapid replication and error prone 
nature of the viral reverse transcriptase which introduces genetic mutations.  Fortunately, there 
are multiple classes of HIV medicines available to control HIV. Different classes of ART allow 
HIV medicines to be interchanged to control an HIV infection following the development or 
introduction of a drug-resistant strain. 
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In the context of HIV-to-HIV transplantation, the recipient is exposed to the donor’s strains 
of HIV and if this includes any drug resistant strains of HIV this could result in complications 
post-transplant if the recipient’s ART is not active against that donor virus. If it is suspected 
that the donor has any drug resistance HIV, the recipient’s ART may need to be altered post-
transplant to control the infection. To assist clinicians in effectively targeting any new strains 
of HIV acquired through transplantation, the donor’s history of treatment and potential drug 
resistance is reviewed and taken into consideration whenever possible.  
Although ART resistance in the US is seen in up to 20% of newly infected individuals, 
multiclass resistant HIV is rare. In addition, recent studies from South Africa suggest that the 
risk of superinfection in an HIV+ recipient receiving ART is low (Selhorst et al. 2019). 
Barriers to Transplant center involvement 
In a study that surveyed 114 national transplant centers, 56% (n=64) of the surveyed centers 
were not planning to perform HIV-to-HIV transplants per the HOPE in Action research criteria, 
though most (91.2%) were aware that HIV-to-HIV transplantation is now legal. Furthermore, 
few centers plan to perform transplants of organs other than kidneys and/or livers (Rasmussen et 
al. 2018). There is also a geographical restriction of transplant centers, with more centers in the 
eastern US planning to adopt HIV-to-HIV transplantation protocols than in the central/western 
US (Rasmussen et al. 2018). This lowers the access of transplantation to patients with HIV, and 
OPOs may be less likely to refer patients with HIV for donation if the local transplant centers 
cannot use the organs.  
The interest of hospitals in implementing HOPE Act policy might be expected to be low, 
as less than 1% of hospital services are related to organ transplantation. However, maintaining 
patients on the organ waitlist is an extremely costly burden to the entire healthcare system: 
Dialysis, the only existing alternative to kidney transplantation, costs the healthcare system an 
average of $28 billion every year (“Statistics.” UCSF 2018). Furthermore, many centers have 
doubts regarding the efficacy of HIV-to-HIV transplantation. Centers not planning to implement 
HOPE Act protocol were more likely to believe that HIV+ candidates would be unwilling to 
accept organs from HIV+ donors, when in actuality, as mentioned earlier, studies suggest a high 
willingness among HIV+ candidates to accept organs from HIV+ donors (Rasmussen et al. 2018). 
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To access greater numbers of HIV+ donors and increase rates of HIV-to-HIV 
transplantation, further efforts are needed to inform and educate potential donors in the 
community of people living with HIV, nurses that recommend patients for organ donation, OPO 
representatives who screen donors, and national transplant centers of the biological risks and 
extensive benefits of HIV-to-HIV transplantation. 
Existing outreach material 
The methods for communicating HOPE Act policy and the potential for increasing life-
saving HIV-to-HIV transplantation previously included the dissemination of brochures, lectures 
and interviews, and short messages through social media that were often less than effective 
at reaching or informing the target audience (Figure 2 and Figure 3). While research has 
shown that using visual materials in addition to written materials can greatly increase patient 
understanding and retention of information (Weiss 2003), there is a need for more efficient, 
engaging, and persuasive visual communication to encourage participation in life-saving HIV-to-
HIV transplantation. 
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Figure 2. Outreach material for people living with HIV. The purpose of this figure is to give examples of 
the educational outreach posters designed for people living with HIV (not all text is intended to be read).
Figure 3. Outreach material for donor hospital nurses and OPO representatives. The purpose of this 
figure is to give examples of the outreach and educational FAQ posters designed for OPO representatives 
and nurses on referring HIV+ organ donors (not all text is intended to be read).
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Audience: challenges and goals 
We (the authors) identified several groups of people in the US that could benefit from 
educational outreach material to help increase rates of HIV-to-HIV transplantation (Figure 4).
1. People living with HIV
2. Nurses at hospitals with trauma centers and OPO representatives
3. Infectous disease care providers
4. Transplant centers
5. Patients with HIV in need of an organ
i. People living with HIV 
As stated previously, only a minority of people living with HIV report being registered as 
organ donors. We hope to (1) alert people living with HIV that it is now legal to register to be an 
organ donor, (2) invite them to consider registering, (3) encourage them to inform their friends 
and family about their decision regarding organ donation, and (4) inspire them to spread the word 
about organ donation in the community of people living with HIV and elsewhere. 
ii. Nurses at hospitals with trauma centers and OPO representatives 
Another potential barrier to identifying HIV+ donors may stem from a lingering stigma 
against HIV affecting donor referrals by nurses and OPO representatives. Following education 
from HOPE outreach material, we hope nurses will make an informed decision to contact the 
OPO every time a potential donor presents, regardless of HIV status. We also hope that OPO 
representatives will likewise consider all referred patients for donation, regardless of HIV status. 
Through these changes, we hope to help reduce HIV stigma and remediate the impact of stigma 
in working with HIV+ potential donors at any point in the organ donation process. 
iii. Infectious disease healthcare providers 
Infectious disease healthcare providers interact with many patients with HIV. Therefore we 
hope to encourage these physicians to inform patients about the HOPE Act and make them aware 
that they can be organ donors.  
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iv. Transplant centers 
To increase HOPE implementation at transplant centers, we will educate administrative and 
coordination staff at these centers of the policy change, address concerns about the efficacy of 
HV+ organ donation, and encourage them to adopt HIV-to-HIV transplantation protocols if they 
have not already done so. 
v. Patients with HIV in need of an organ 
HIV+ transplant candidates must give their consent before potentially accepting an organ 
from someone with HIV. The current methods for communicating the risks of receiving an HIV-
infected organ consist solely of written materials developed for patients. We hope to educate 
potential HIV+ recipients about the safety and risks of receiving an organ from an HIV+ donor in 
a way that is engaging and easily understandable. 
Figure 4. Potential audiences and calls to action. This graphic depicts the potential groups to address and 
the request for each.
Effectiveness of animation as a teaching tool 
The rise of online communication has presented new possibilities to communicate 
information more attractively and with greater accessibility, especially for those with low health 
literacy. Information can be presented online in various modes of delivery, such as interactive 
graphics, videos, or animations (Meppelink et al. 2015). Animation has been perceived as 
an effective and engaging tool for disseminating complex information, with better learning 
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outcomes compared to static illustrations (Meppelink et al. 2015). Short and concise animations 
have been proven to enhance learning by simplifying complex, abstract science concepts and 
engaging the viewer with critical thinking and problem solving skills (Chan 2013). Furthermore, 
the effectiveness of educational visual animation is increased when coupled with audio 
commentary (Berney et al. 2016). 
Effectiveness of animation in lower health literacy populations 
Of the 1.1 million people aged 13 and older who were diagnosed with HIV in the United 
States in 2018, almost 70% are of Black/African American and Hispanic/Latino ethnicities 
(“Statistics Overview.” Centers for Disease Control and Prevention 2019). Additionally, HIV 
diagnoses occur most commonly in individuals aged 20-29 but can also occur in older adults and 
children (“Statistics Overview.” Centers for Disease Control and Prevention 2019). Lower health 
literacy is often common and problematic among older adults, ethnic minorities, and those with 
a lower level education (Nguyen et al. 2015).  A lack of adequate, accessible communication 
of health information to multicultural minorities contributes to health disparities among these 
populations (George et al. 2013). Fortunately, communicating health related information via 
animation has been shown to improve the ability of audiences with lower health literacy to 
comprehend, understand, and ask questions about health information and research. Furthermore, 
enhancing understanding of health information can enable minority multicultural individuals to 
make educated decisions about their health and health research participation (George et al. 2013).   
Communicating the governmental policy change following the HOPE Act and the safety and 
risks of HIV-to-HIV transplantation through engaging animations is expected to educate these 
audiences and provide the groundwork to inspire them to consider organ donation. Furthermore, 
this objective satisfies the frequent requests from OPOs for more materials to explain the HOPE 
Act policy change to hospital nurses in what is called “hallway education”. Patient care can be 
deescalated when patients are not referred for potential organ donation; anecdotal data suggests 
critically ill HIV+ patients had been turned away by nurses before an OPO representative could 
discuss organ donation with the patients’ families. Therefore, nurses often need additional tools 
to understand the policy change following the HOPE Act, and a brief animation for hallway 
education is expected to resolve this problem. 
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Theories of learning 
Individuals with low health literacy often lack the background health information to fully 
understand the information presented in educational materials, and therefore are at risk of 
cognitive overload when presented with complex medical information (Meppelink et al. 2015). 
When designing an educational animated visual, it is imperative to implement learning theories 
to minimize cognitive load and maximize the learning outcomes for a specified audience. 
The Cognitive Theory of Multimedia Learning declares three principles: (1) there are two 
channels for processing information: audio and visual, (2) people can only process a limited 
amount of information in each channel, and (3) learning is an active process of filtering and 
integrating information based upon previous knowledge (Mayer. 2012). For example, when 
played in conjunction, animated visuals and on-screen text are processed simultaneously, and the 
viewer must subsequently divide their attention between both. The modality principle suggests 
that learning is more effective when visuals are accompanied by audio narration versus solely on-
screen text. However, select relevant words that appear on-screen simultaneously with narration 
utilize both audio and visual channels and promote active retention of information, as stated by 
the redundancy principle (Mayer. 2012). 
To minimize cognitive load in these animations, the primary script information was 
delivered through audio narration, and on-screen text was minimized. Any on-screen labels 
were timed with the narration to boost retention through utilization of both audio and visual 
channels. Additionally, the contiguity principle suggests that learning is more effective when 
relevant information is presented closely together in visual space. Any on-screen labels of visual 
structures were placed in close proximity to the structures, or a leader line was used to directly 
pair the label to the structure for easier association and effective learning (Figure 5). 
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Figure 5. Redundancy and contiguity principles examples. This still from the animation shows examples 
of the redundancy and contiguity principles in action. These labels appear when mentioned in the narration, 
and in addition, they are directly connected to their associated structures with leader lines.
The personalization principle suggests that a narration with an informal and conversational 
tone conveys more of a social presence and helps to promote deeper learning. A voiceover artist 
with a gentle, reassuring voice was chosen to relate to the audience and engage the viewer in 
active, effective learning (Kurt 2011). Lastly, the learner control principle states that being able to 
control the rate of learning can help viewers learn more effectively. Communicating HOPE Act 
policy and the risks of HIV-to-HIV transplantation through animation provides the opportunity 
to incorporate this principle: when the animations are shared with the specified audiences, 
controls will be available to pause the videos for a self-paced learning experience. 
Designing the content to be communicated  
To efficiently create animations for the previously established audiences, we developed a 
workflow to create reusable animations that are tailored to each audience with customizable calls-
to-action (Figure 6). To design the reusable clips that were to be unlocked for each audience, 
we identified the information that each group would benefit from learning to make an informed, 









































































































































































































































Framing the issue by explaining the history of the HOPE Act will help viewers understand 
the social and historical impact of this important policy change. While most people are aware of 
the nationwide organ shortage, an explanation of the disparity of mortality rates on the waitlist 
could help contextualize the heightened risk HIV+ patients face while waiting for an organ. 
Additionally, the current state of organ transplantation for patients with HIV was described: for 
years, recipients with HIV had received organs from only HIV- donors, with equal long term 
success to recipients without HIV. This was followed by an introduction to the HOPE Act of 
2013, which explained the early successful outcomes of HIV-to-HIV transplantation and revealed 
the substantial potential to increase the donor organ pool by making organs from people with 
HIV available for organ donation. Presenting these disparities and following with the feasibility 
and success of the HOPE Act laid the groundwork to delve into the science of how HIV-to-HIV 
transplants as well as the risks that are associated with them. 
However, consenting patients considering receiving an organ from an HIV+ donor would 
already be aware of this legalization through their participation in the HOPE in Action research 
study. For the sake of brevity and to avoid redundancy, the background information clip was 
omitted for these consented patients. 
Addressing the Risks 
To address the concern regarding the safety and efficacy of HIV+ organ donation and 
HIV-to-HIV transplantation, the unique biological risks of HIV-to-HIV transplantation were 
discussed. While infectious disease healthcare providers are familiar with the genetic diversity 
of HIV, people with HIV may be less familiar with this principle. Therefore, a brief overview of 
the science of HIV would provide the proper background information for each audience to delve 
into the biological risks. The life cycle of HIV was first explained, followed by the ability of HIV 
to mutate and create unique strains before it infects other host cells to continue its life cycle. 
To reassure viewers, ART and its ability to control an HIV infection was explained. The great 
success of modern ART was described, as well as the shift of HIV to a controllable condition and 
the benefits on the long-term health of people with HIV. 
This background information set the stage to introduce the main biological risk of HIV-
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to-HIV transplantation: superinfection. While superinfection is not a characteristic unique to 
HIV, it is a relatively unfamiliar concept to patients and even healthcare professionals in other 
fields of medicine. Defining superinfection in the context of HIV-to-HIV transplantation would 
be beneficial information for each of the audiences—especially the HIV+ patients considering 
receiving an organ from an HIV+ donor, as the animation would be provided alongside the study 
consent paperwork that explains the risks. It is worth noting that the risk of organ rejection was 
not addressed, since it is pertinent to all organ transplantation, not just those involving HIV+ 
donors and recipients. 
The aim of this clip is to address concerns about the unique risks of HIV-to-HIV 
transplantation and reassure viewers that the likelihood of these risks is low. By explaining these 
risks in the context of the science of HIV, this clip is expected to help alleviate concerns from 
transplant centers, hospital nurses, and OPO representatives, and hopefully also help mitigate 
stigma of HIV in these groups. 
Conclusion 
Additionally, each audience would benefit from a concluding summary that highlights the 
success to date of HIV-to-HIV transplantation and reinforces that their participation is essential 
to the future success of such transplants. This section also provides the opportunity to reassure 
patients and healthcare professionals that participation in HIV-to-HIV transplantation is worth 
the negligible risk of superinfection to HIV+ recipients compared to the high risk of dying on the 
waitlist. 
Call to Action 
Lastly, each animation concludes with a unique call-to-action that informs the viewers on 
how they can participate. These clips serve to encourage:
1. People living with HIV to consider registering to be an organ donor, to talk to 
their friends and family to make their decision about organ donation known, and 
to spread the word of organ donation in the community of people living with 
HIV and elsewhere. 
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2. Critical care nurses to consider all patients equally when referring patients to 
an OPO for screening, and OPO representatives to consider all patients equally 
when evaluating them for donation, regardless of HIV status.
3. Infectious disease healthcare providers to inform their patients with HIV of 
the legalization of using organs from HIV+ donors in transplantation, and to 
encourage their patients to consider registering to be an organ donor.
4. Transplant centers and teams to consider implementing HOPE Act policy and 
adopting HIV-to-HIV transplantation if it is not already in practice.
5. HIV+ patients who are consenting to receive an HIV+ donor organ to continue 
the discussion with their care providers.
Audiences addressed in this project 
To create a realistic deliverable in the time allotted to this project, we distilled all of the 
potential audiences to the most essential groups where change would have the greatest impact 
and ultimately increase rates of HIV-to-HIV transplantation (Figure 7). As stated previously, 
we hypothesize that the largest loss of potential HIV+ donors stems from existing HIV stigma 
in donor referrals by nurses and OPO representatives. Another major barrier to identifying more 
potential HIV+ donors is the low rate of donor registration in the community of people living 
with HIV. Therefore, we decided to address (1) people living with HIV and (2) donor hospital 
































































































































































Script reading level for multiple audiences 
While precise medical terminology is essential when communicating to healthcare 
professionals and those with a technical medical background, patients often do not grasp the 
intended meaning of this complex language, particularly those with lower health literacy. 
Reaching the target audience through plain language is vital in effective communication to 
patients (“Find Your Local Organ Procurement Organization.” Health Resources & Services 
Administration 2020). Since both patients and healthcare providers were addressed in these 
reusable animations, we investigated diverging the script narration for the reusable clips into two 
versions: a descriptive script with exact medical terminology for nurses and OPO staff, and a 
simplified, streamlined script for patients with HIV that would be played over the same animated 
visuals. 
However, after discussion with Dr. Durand, an additional role of the animations was 
identified.  OPOs employ a variety of staff, including organ procurement coordinators, 
requesters, specialists who communicate with donor families, professionals in public relations 
communications and health education, as well as administrative personnel. While nurses caring 
for critically ill patients tend to have a high degree of medical knowledge, OPO representatives 
who evaluate patients for donation may not have the same level of medical knowledge to 
understand complex terminology. 
Therefore, patient-level script language for nurses and OPO representatives would 
familiarize them with accepted HIV terminology and prepare them to work with patients with 
HIV. Although patients generally are found to have lower health literacy (Ishikawa et al. 2008), 
patients with HIV often have a higher level of understanding of HIV and their condition. It was 
therefore feasible to determine a level of information to reach both audiences and create a script 
that used medical terminology that people with HIV are comfortable with and that nurses and 
OPO representatives should become familiar with. 
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Objectives 
The goal of this project was to create reusable animations with tailored calls-to-action 
that will help to increase awareness of the HOPE Act, help to mitigate stigma against HIV, and 
encourage participation in HIV-to-HIV transplantation. The objectives of this project include:
1. Create reusable clips and customized call-to-action clips for (1) people living 
with HIV and (2) nurses and OPO representatives.
2. Script and record the narrations for both audiences.
3. Combine clips and narrations to produce cohesive animations tailored for each 
audience.
The animations will educate people living with HIV, donor hospital nurses, and OPO 
representatives about the success of the HOPE Act and the risks of HIV-to-HIV transplantation. 
The animations are further expected to decrease HIV stigma in HIV+ donor referrals and 
encourage participation in HIV-to-HIV transplantation in these groups.
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Materials and Methods
After identifying the target audiences for this project and determining the content to be 
communicated, the workflow for this project was as follows:
1. Script language and development
2. Voice Over production
3. Storyboard creation 
4. Style development and animation
• Style of science clips
• Color Blindness test
5. Animation in Adobe After Effects
i. Script language and development 
Following the approximate outline of content described earlier, a written narrative of 
the story was developed with language that is relative to and easily understandable by both 
audiences: people living with HIV and nurses and OPO staff. As previously mentioned, the 
script was composed at a level appropriate for patients with HIV, with simplified patient-friendly 
language and select medical terminology. In addition, awareness of patient-level terminology will 
help to prepare nurses and OPO representatives for effective patient communication. 
To determine the appropriate medical terminology for patients with HIV for the scientific 
portion of the animation, I referenced the language used in a consent form (HOPE in Action 
Multicenter Kidney Study, 2019) for HIV+ candidates who are considering  an HIV+ organ 
transplant. For example, the form contains a section titled “Risks and/or Discomforts” that 
presents risks to a patient receiving an organ from an HIV+ donor. The form introduces “HIV 
Superinfection,” which is also the clinical term used by healthcare providers, and explains 
superinfection in a second person point of view, referring to the patient as “you” and donors as 
“HIV+ donors.” However, some terms were softened for the intended patient audience: ART was 
referred to as “HIV medications,” a strain of HIV is referred to as “a type of HIV,” and drug-
resistant HIV was referred to as “difficult-to-control HIV.” 
Following discussion with the consent form’s author, Dr. Durand, some of these language 
changes were incorporated into the script. HIV superinfection is an important term that 
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is frequently referenced in HIV patient care, therefore, both audiences would benefit from 
becoming familiar with it . Similarly, HIV strain was used instead of “a type of HIV” to 
familiarize patients, nurses, and OPO representatives with the  term. However, the more patient-
friendly term HIV medicines was adopted instead of using ART since exact terminology is more 
important when explaining the transplant risks than when sharing scientific information about 
HIV. 
In addition, since the individualized calls to action serve to encourage the viewer to take 
action, it was feasible to directly address each audience with a second person point of view and 
refer to the viewer as you. However, since two separate groups of people were addressed in the 
reusable clips, which serve to present information rather than persuade the viewer, second person 
point of view was not used when communicating to both audiences in these clips. 
Furthermore, it is becoming common to use more courteous, person-first language when 
referring to people with an HIV infection. Throughout the script, individuals were referred to 
as people living with HIV rather than HIV+ individuals to reinforce the perception of HIV as 
a long-term, manageable, condition. This guideline also applied when referring to donors and 
recipients with HIV. 
Keeping these concepts in mind, the script was developed following an iterative workflow 
with revisions by content experts. The final script was as follows:
Introduction
1. Nearly 114,000 people in the United States are currently in need of an organ 
transplant.
2. Every day, over 100 people are added to the waitlist, and 20 will die having never 
received the lifesaving transplant they needed.
3. A growing number of those waiting are also living with HIV, and are more likely to die 
waiting for a transplant.
4. In the past, organs from donors with HIV were considered unsafe, and were banned 
from use in transplantation.
5. Historically, people with HIV received organ donations from people without HIV.
6. However, studies show that they can also receive organs from people with HIV, with 
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equally successful outcomes.
7. The HIV Organ Policy Equity Act, or HOPE Act, was passed in two thousand thirteen, 
and legalized transplanting organs from donors with HIV to people who also have 
HIV.
8. Thanks to the HOPE Act, people in need of an organ are more likely to receive a 
transplant:
9. Transplanting organs between donors and recipients with HIV provides more organs 
for people without HIV, and creates more life-saving transplants every year.
Addressing the Risks
Life Cycle and Strains of HIV
1. How is it possible that patients with HIV can receive organs from donors who also 
have HIV?
2. HIV is a virus that primarily infects the body’s white blood cells.
3. The virus enters a host cell, where it makes copies of itself using the host cell’s 
machinery.
4. As it replicates, HIV has the ability to mutate and change over time, which creates 
unique strains of HIV that can differ from person to person.
5. The virus then leaves the cell to locate a new host and continue its life cycle.
How HIV Medications Work
6. HIV medicines work by blocking replication and preventing the spread of HIV to other 
cells, which minimizes levels of HIV in the body.
7. Decades of research into HIV medicines has allowed HIV to become a controlled 
condition rather than a deadly disease.
8. However, when HIV mutates it can become resistant to medication.
9. Fortunately, there are multiple classes of HIV medicines that block HIV replication in 
different ways.
10. If HIV becomes resistant to one class of medicines, others can be substituted to control 
an HIV infection.
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Risks of Receiving an Organ from a Donor with HIV
11. When someone with HIV is given an organ from a donor with HIV, new strains of the 
virus can be introduced with the organ. 
12. Fortunately, the recipient’s current HIV medicines are likely to control the new strains 
from the donor. 
13. However, the recipient could become infected with the new strains, in addition to their 
existing HIV infection. This is called superinfection.
14. If superinfection occurs, different HIV medicines will be tried until an effective new 
combination is found. 
15. Fortunately, studies show that the risk of superinfection is low, compared to the 
greater risk of dying while waiting for an organ.
Conclusion
1. Organ transplantation between donors and recipients with HIV is an important step 
towards shortening the waitlist for organ transplants. 
2. Under the HOPE Act, 500-600 new donors are expected to be available in the US 
annually, and up to 10,000 people with HIV could benefit from this change.
3. Your support and participation can help maximize these life-saving transplants
Call-to-action: Register to be an organ donor
People living with HIV
1. We ask that you consider registering to be an organ donor, because that one decision 
could save lives. 
2. Register at the DMV or online at registerme.org, and talk to your friends and family to 
make your decision about organ donation known. 
3. You do not have to disclose your HIV status in order to register.
4. We also ask that you help raise awareness of the importance of organ donation in the 
community of people living with HIV to continue these life saving transplants.
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Call-to-action: Consider all patients equally in HIV+ donor referrals
Donor hospital nurses and OPO representatives
1. When referring a patient for organ donation, HIV status should not change your 
perception of your patient’s potential to save lives.
2. Patients can be newly diagnosed with HIV, in care for HIV, or potentially HIV-positive 
pending serological testing.
3. Even if a patient has never been in care for HIV, they still have the potential to save 
lives. 
4. The HOPE Act does not require disclosure of HIV status to the patients’ families in 
order to be an organ donor.
5. When an OPO receives a call about a potential donor with HIV, they can contact 
the HOPE in Action study at Johns Hopkins, for assistance with clinical evaluation, 
approach, and organ allocation.
ii. Voice over production 
As stated previously, the personalization principle of the Cognitive Load Theory suggests 
that an informal and conversational tone of narration conveys a social presence and helps to 
promote deeper learning. Additionally, the signaling principle states that pauses in narration can 
help the viewer learn more efficiently by signaling and emphasizing important aspects of the 
provided information (Mayer 2014). 
The voice over narration was recorded by Andy Zeiger, whose voice is warm, clear, and 
animated. Under my direction, he accented specific, important words with inflection and varied 
the pitch of his voice to create a flowing sentence structure. Select pauses were accentuated to 
emphasize important information. The goal of the narration was to inform the viewer by means 
of a clear, conversational voiceover that the viewer can understand and relate to.   
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iii. Storyboard creation 
A storyboard can be referred to as the first visualization of the story (Wright 2013). Using 
the script as a guide visuals are proposed to assist and clarify the content. The storyboard serves 
multiple purposes in the animation process. It helps to: (1) give a visual outline of the animations, 
(2) determine the number of assets needed, (3) determine the length and timing of scenes when 
the script is incorporated, and (4) establish a visual style to serve as a guide for asset creation. 
Multiple iterations of the storyboards were developed following feedback from content 
experts, and the script underwent many changes as the visuals developed (Figure 8;      
Appendix A).
Figure 8. Selected storyboards from the Addressing the Risks clip. This figure shows an example of the 
storyboards created for this project (text not intended to be read).
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iv. Style development and animation 
When visualizing organ transplantation to both target audiences, a human figure was 
considered to depict the transplanting of organs between donors and recipients. However, the 
goal of this project was to create welcoming and relatable educational  material that (1) promotes 
inclusivity in the community of people living with HIV and (2) helps to mitigate any HIV stigma 
stemming from preconceived bias in HIV+ donor referrals. Since the viewer might be expected 
to subconsciously associate a human figure with themselves or others, an alternative visual was 
developed to represent recipients and donors with and without HIV. 
A visual system was established to differentiate these individuals without using a human 
figure. Individuals were identified with contrasting shapes and colors as shown in Figure 9. All 
HIV- individuals were represented with a circle, and HIV+ individuals were represented with a 
diamond. HIV- recipients were blue, HIV+ recipients were a contrasting orange, and all organ 
donors, regardless of HIV status, were depicted with white. 
Additionally, this identification system was also applied when referring to people on the 
waitlist who have died waiting for an organ transplant. A new style was developed for these 
individuals, also seen in Figure 9. Deceased HIV- patients were depicted with blue circles, and 
HIV+ patients were depicted with orange diamonds. 
Furthermore, giving life to an individual with an organ transplant was conveyed through 
a metaphor of light, and transplantation was depicted as transferring light from a donor to a 
recipient. Hollow symbols depicting patients in need of a transplant were illuminated and filled in 
after receiving an organ transplant from a donor (Figure 10).
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Figure 9. Established system to identify donors and recipients with and without HIV. All HIV- 
individuals were represented with a circle (a, c, and e), and HIV- individuals were represented with a 
diamond (b, d, and f). (a) HIV- patient on the waitlist, (b) HIV+ patient on the waitlist, (c) HIV- organ 
donor, (d) HIV+ organ donor, (e) deceased HIV- patient, and (f) deceased HIV+ patient.
Figure 10. Organ transplantation between donors and recipients. Example frame sequence from the 
final animation showing the visual for organ transplantation between an HIV+ donor (left) and an HIV+  
recipient (right).
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As stated previously, the redundancy and contiguity principles suggest that retention of 
information is increased when select words from the audio appear on-screen in conjunction with 
the narration, and when related  structures and labels are placed in close proximity (Mayer 2012). 
For easier understanding of the previously mentioned donor/recipient identification system, labels 
were used to call out each representational visual as they appeared in the animations, and leader 
lines were used to associate them with the correct structures (Figure 11). 
Figure 11. Labeling to identify HIV+ and HIV- donors and recipients. Example of the labels used to 
identify an HIV- donor and an HIV+ recipient from the final animation.
Style of science clips 
A clear and effective style of animation was developed to communicate complex scientific 
topics such as HIV superinfection to the target audiences. Furthermore, since one of the 
audiences consisted of a patient group, a simplified depiction of cellular and viral mechanisms 
was used (Figure 12). Hyper-realistic rendering of such mechanisms would provide an 
unnecessary and potentially distracting amount of detail, which could increase cognitive load in 
a patient audience and hinder effective learning.
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Color Blindness Test 
Since the established color system was important to differentiate donors and recipients 
with and without HIV, the resulting style was tested for individuals with colorblindness using an 
online simulator. A frame from the final animation was tested in red-weak/protanomaly, green-
weak/deuteranomaly, blue-weak/tritanomaly, red-blind/protanopia, green-blind/deuteranopia, 
blue-blind/tritanopia, monochromacy/achromatopsia, and blue cone monochromacy individuals 
(Figure 13).
Figure 12. Style of science clips. An example still from the final animation showing the simplified style of 
science communication to explain topics such as the development of HIV strains within a white blood cell 
host.
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Figure 13. Color blindness test. Still frame from the introduction to test for the usability by color 
blindness individuals. (a) normal, (b) red-weak/protanomaly, (c) green-weak/deuteranomaly, (d) blue-
weak/tritanomaly, (e) red-blind/protanopia, (f) green-blind/deuteranopia, (g) blue-blind/tritanopia, (h) 
monochromacy/achromatopsia, and (i) blue cone monochromacy.
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v. Animation in Adobe After Effects 
The final artwork assets were created in Adobe After Effects. A clean, simplified 2D style 
was developed to create a time-efficient and easy to follow animation. However, drop shadows 
(Figure 14) and texturizing techniques (Figure 15) were used with consistent light direction to 
create the appearance of a 3D animation with extruded shapes and floating linework.
Figure 14. Drop Shadow effect. These figures show the application of drop shadows to add 
3-dimensionality to 2D artwork. The direction of shadows is kept consistent throughout the animations to 
give the appearance of more realistic lighting (not all text intended to be read).
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Figure 15. Texturize effect. This figure describes adding texture to a 2D layer in After Effects. The 
texturize effect (a) creates the illusion of surface topology using a selected layer and light direction.
The source layer (b) was a flat image created from a texture brush in Procreate to create the final 
textured result (c).
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During the Addressing the Risks clip, the Puppet Position Pin Tool was used to add organic 
movement to the relatively static host cell. Pins were placed around the cell membrane and 
manipulated slightly throughout the timeline to give the appearance of a wave-like movement 
(Figure 16). 
Furthermore, to create the illusion of a malleable cell membrane that reacts to physical 
forces, specific movements were keyframed with the Puppet Position Pin Tool. When the HIV 
virion pressed against the host cell, the host cell membrane stretched inwards slightly before 
recoiling quickly after the viral membrane merged with the host cell and the HIV RNA was 
inserted into the cell (Figure 17). 
Figure 16. Puppet Position Pin Tool for organic movement. This figure shows the location of the 8 
puppet pins used to add organic movement to the host white blood cell (not all text intended to be read).
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Addition of the Wiggle expression added subtle movement to the HIV virions throughout the 
clip (Figure 18). The Wiggle expression was used with both positional and rotational directions 
for more dynamic movements. In addition, the Wiggle expression was also included in the 
position and rotation movements of the entire Addressing the Risks clip to mimic a camera shake 
and to give the impression of a dynamic cellular environment.
Figure 17. Puppet Position Pin Tool for organic 
movement. These figures show the deformation 
of the host cell membrane to give the illusion of a 
malleable and elastic membrane during HIV entry. 
Extracellular space is to the left of the membrane 
and intracellular space is to the right.
Figure 18. Opening the Expression dialogue box. After 
opening the position or rotation drop-down menus on a 
layer (a), the stopwatch is clicked while pressing the Alt-
Option key on a Mac to open the Expression dialogue box 
(b). The wiggle expression (c) is then entered to provide 
random movements, which can be controlled by the 






In total, two standalone animations were created in this project that address two distinct 
audiences: (1) people living with HIV and (2) nurses at hospitals with trauma centers and OPO 
representatives. The animations were created from reusable introduction, body, and conclusion 
clips as well as call-to-action clips that were customized to each audience. The narration was 
simplified to a level of complexity for patients with HIV, to better prepare hospital nurses and 
OPO staff for communicating important concepts with patients.  
The final animation for people living with HIV resulted in a video file 4 minutes and 22 
seconds in duration  (4 minutes and 11 seconds without credits). The final animation for nurses 
and OPO representatives resulted in  a video file 4 minutes and 37 seconds in duration (4 minutes 
and 26 seconds without credits (Appendix B). In addition to the final animations, 3 sets of 
storyboards were developed in preparation for the animations (Appendix A). 
Changes during the project 
The identification system established in the storyboards was changed during production to 
further help the viewer identify donors and recipients with and without HIV. Individuals with 
HIV were differentiated from those without HIV using diamonds rather than only circles for 
both groups as originally planned. Furthermore, labels were added throughout the animation to 
increase understanding of the on-screen structures. 
Project objectives 
The primary goals of this project were to create two reusable animations with tailored 
calls-to-action that will educate people living with HIV, donor hospital nurses, and OPO 
representatives about the success of the HOPE Act and the risks of HIV-to-HIV transplantation. 
In addition, the animations were also expected to decrease HIV stigma in HIV+ donor referrals 
and encourage participation in HIV-to-HIV transplantation in these groups. 
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Future considerations 
Future directions for this project involve completing the Call-to-Action clips for the three 
remaining audiences not addressed in this portion of the project. Since HIV superinfection in the 
context of organ transplantation is a frequently misunderstood topic, the “Addressing the Risks” 
clip should be turned into a standalone animation to be presented by Drs. Dorry Segev and 
Christine Durand in their lectures to their clinical colleagues in the fields of organ donation and 
transplantation. 
In addition, the animation for transplant hospital nurses and OPO staff will be presented at 
HIV clinics and future annual meetings for: Association for Organ Procurement Organizations, 
Organization for Transplant Professionals, and Association of Nurses in AIDS Care. 
Furthermore, the effectiveness of the learning content created during this project is yet 
to be tested. For future study, a pre- and post- test may be administered to a random group 
of individuals from each intended audience, and statistical analyses used to evaluate the 
effectiveness of the animations in reaching the previously listed objectives. 
Access to thesis animations 
The final animations from this thesis can be viewed at morgansummerlin.com or by 
contacting the author through the website’s contact form. The author may also be reached through 
the Department of Art as Applied to Medicine via the website medicalart.johnshopkins.edu.
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Appendices
Appendix A: Storyboards 
Reusable Clips Storyboards for Animations 1 and 2
Figure 19.1. Storyboard 1 for Animations 1 and 2. Storyboard frames for the reusable components for 
both animations (text not intended to be read).
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Figure 19.2. Storyboard 2 for Animations 1 and 2. Storyboard frames for the reusable components for 
both animations (text not intended to be read).
Figure 19.3. Storyboard 3 for Animations 1 and 2. Storyboard frames for the reusable components for 
both animations (text not intended to be read).
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Figure 19.4. Storyboard 4 for Animations 1 and 2. Storyboard frames for the reusable components for 
both animations (text not intended to be read).
Figure 19.5. Storyboard 5 for Animations 1 and 2. Storyboard frames for the reusable components for 
both animations (text not intended to be read).
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Figure 19.6. Storyboard 6 for Animations 1 and 2. Storyboard frames for the reusable components for 
both animations (text not intended to be read).
Figure 19.7. Storyboard 7 for Animations 1 and 2. Storyboard frames for the reusable components for 
both animations (text not intended to be read).
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Call-to-Action Storyboard for Animation 1: 
People living with HIV
Figure 20. Storyboard for Animation 1. Storyboard frames for the Call-to-Action clip for the people 
living with HIV animation (text not intended to be read).
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Call-to-Action Storyboard for Animation 2: 
Nurses at hospitals with trauma centers and OPO representatives
Figure 21. Storyboards for Animation 2. Storyboard frames for the Call-to-Action clip for the donor 
hospital nurses and OPO representatives animation (text not intended to be read).
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Appendix B: Selected Animation Stills 
Reusable Clips for Animations 1 and 2
Figure 22.1. Still for Animations 1 and 2. Opening screen.
Figure 22.2. Still for Animations 1 and 2. Audio: Nearly 114,000 people in the United States are currently 
in need of an organ transplant. 
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Figure 22.4. Still for Animations 1 and 2. Audio: …and 20 will die having never received the lifesaving 
transplant they needed.
Figure 22.3. Still for Animations 1 and 2. Audio: Every day, over 100 people are added to the waitlist…
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Figure 22.6. Still for Animations 1 and 2. Audio: …and are more likely to die waiting for a transplant.
Figure 22.5. Still for Animations 1 and 2. Audio: A growing number of those waiting are also living with 
HIV…
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Figure 22.8. Still for Animations 1 and 2. Audio: …were considered unsafe, and were banned from use in 
transplantation.
Figure 22.7. Still for Animations 1 and 2. Audio: In the past, organs from donors with HIV…
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Figure 22.10. Still for Animations 1 and 2. Audio: …received organ donations from people without HIV
Figure 22.9. Still for Animations 1 and 2. Audio: Historically, people with HIV…
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Figure 22.12. Still for Animations 1 and 2. Audio: The HIV Organ Policy Equity Act…
Figure 22.11. Still for Animations 1 and 2. Audio: However, studies show that they can also receive 
organs from people with HIV, with equally successful outcomes.
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Figure 22.14. Still for Animations 1 and 2. Audio: …was passed in two thousand thirteen, and legalized 
transplanting organs from donors with HIV to people who also have HIV.
Figure 22.13. Still for Animations 1 and 2. Audio: …or HOPE Act…
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Figure 22.16. Still for Animations 1 and 2. Audio: Transplanting organs between donors and recipients 
with HIV provides more organs for people without HIV…
Figure 22.15. Still for Animations 1 and 2. Audio: Thanks to the HOPE Act, people in need of an organ 
are more likely to receive a transplant:
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Figure 22.18. Still for Animations 1 and 2. Audio: How is it possible that patients with HIV can receive 
organs from donors who also have HIV?
Figure 22.17. Still for Animations 1 and 2. Audio: … and creates more life-saving transplants every year.
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Figure 22.20. Still for Animations 1 and 2. Audio: The virus enters a host cell…
Figure 22.19. Still for Animations 1 and 2. Audio: HIV is a virus that primarily infects the body’s white 
blood cells.
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Figure 22.22. Still for Animations 1 and 2. Audio: As it replicates, HIV has the ability to mutate and 
change over time, which creates unique strains of HIV that can differ from person to person.
Figure 22.21. Still for Animations 1 and 2. Audio: …where it makes copies of itself using the host cell’s 
machinery.
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Figure 22.24. Still for Animations 1 and 2. Audio: HIV medicines work by blocking replication and 
preventing the spread of HIV to other cells, which minimizes levels of HIV in the body.
Figure 22.23. Still for Animations 1 and 2. Audio: The virus then leaves the cell to locate a new host and 
continue its life cycle.
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Figure 22.26. Still for Animations 1 and 2. Audio: However, when HIV mutates…
Figure 22.25. Still for Animations 1 and 2. Audio: Decades of research into HIV medicines has allowed 
HIV to become a controlled condition rather than a deadly disease.
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Figure 22.28. Still for Animations 1 and 2. Audio: Fortunately, there are multiple classes of HIV 
medicines that block HIV replication in different ways.
Figure 22.27. Still for Animations 1 and 2. Audio: …it can become resistant to medication.
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Figure 22.30. Still for Animations 1 and 2. Audio: …others can be substituted to control an HIV 
infection.
Figure 22.29. Still for Animations 1 and 2. Audio: If HIV becomes resistant to one class of medicines…
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Figure 22.32. Still for Animations 1 and 2. Audio: Fortunately, the recipient’s current HIV medicines are 
likely to control the new strains from the donor.
Figure 22.31. Still for Animations 1 and 2. Audio: When someone with HIV is given an organ from a 
donor with HIV, new strains of the virus can be introduced with the organ. 
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Figure 22.34. Still for Animations 1 and 2. Audio: If superinfection occurs, different HIV medicines will 
be tried until an effective new combination is found.
Figure 22.33. Still for Animations 1 and 2. Audio: However, the recipient could become infected with the 
new strains, in addition to their existing HIV infection. This is called superinfection.
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Figure 22.36. Still for Animations 1 and 2. Audio: Organ transplantation between donors and recipients 
with HIV…
Figure 22.35. Still for Animations 1 and 2. Audio: Fortunately, studies show that the risk of 
superinfection is low, compared to the greater risk of dying while waiting for an organ.
61
Figure 22.38. Still for Animations 1 and 2. Audio: Under the HOPE Act, 500-600 new donors are 
expected to be available in the US annually…
Figure 22.37. Still for Animations 1 and 2. Audio: …is an important step towards shortening the waitlist 
for organ transplants.
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Figure 22.40. Still for Animations 1 and 2. Audio: …and up to 10,000 people with HIV could benefit 
from this change.
Figure 22.39. Still for Animations 1 and 2. Transition.
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Figure 22.42. Still for Animations 1 and 2. Audio: …can help maximize these life-saving transplants.
Figure 22.41. Still for Animations 1 and 2. Audio: Your support and participation…
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Call-to-Action Clip for Animation 1: 
People living with HIV 
Figure 23.1. Still for Animation 1. Audio: We ask that you consider registering to be an organ donor, 
because that one decision could save lives.
Figure 23.2. Still for Animation 1. Audio: Register at the DMV…
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Figure 23.3. Still for Animation 1. Audio: …or online at registerme.org…
Figure 23.4. Still for Animation 1. Audio: …and talk to your friends and family to make your decision 
about organ donation known.
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Figure 23.5. Still for Animation 1. Audio: You do not have to disclose your HIV status in order to register.
Figure 23.6. Still for Animation 1. Audio: We also ask that you help raise awareness of the importance of 
organ donation in the community of people living with HIV…
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Figure 23.7. Still for Animation 1. Audio: … to continue these life saving transplants.
Figure 23.8. Still for Animation 1. Credit screen.
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Call-to-Action Clip for Animation 2: 
Nurses at hospitals with trauma centers and OPO representatives
Figure 24.1. Still for Animation 2. Audio: When referring a patient for organ donation…
Figure 24.2. Still for Animation 2. Audio: …HIV status should not change your perception of your 
patient’s potential to save lives.
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Figure 24.3. Still for Animation 2. Audio: Patients can be newly diagnosed with HIV…
Figure 24.4. Still for Animation 2. Audio: …in care for HIV…
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Figure 24.5. Still for Animation 2. Audio: …or potentially HIV-positive pending serological testing.
Figure 24.6. Still for Animation 2. Audio: Even if a patient has never been in care for HIV, they still have 
the potential to save lives.
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Figure 24.7. Still for Animation 2. Audio: The HOPE Act does not require disclosure of HIV status to the 
patients’ families…
Figure 24.8. Still for Animation 2. Audio: …in order to be an organ donor.
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Figure 24.9. Still for Animation 2. Audio: When an OPO receives a call about a potential donor with HIV, 
they can contact the HOPE in Action study at Johns Hopkins, for assistance with…
Figure 24.10. Still for Animation 2. Audio: …clinical evaluation, approach, and organ allocation.
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Figure 24.11. Still for Animation 2. Credit screen.
74
References
Bansal, Ankit, James Willig, and Nathan Erdmann. “2260. HIV Transplantation Awareness and At-
titudes Following Implementation of the HOPE Act.” Open Forum Infectious Diseases 5, no. 
suppl_1 (2018). https://doi.org/10.1093/ofid/ofy210.1913.
Berney, Sandra, and Mireille Bétrancourt. “Does Animation Enhance Learning? A Meta-Analysis.” 
Computers & Education 101 (2016): 150–67. https://doi.org/10.1016/j.compedu.2016.06.005.
Boyarsky, B. J., C. M. Durand, F. J. Palella, and D. L. Segev. “Challenges and Clinical Decision-
Making in HIV-to-HIV Transplantation: Insights From the HIV Literature.” American Journal of 
Transplantation 15, no. 8 (2015): 2023–30. https://doi.org/10.1111/ajt.13344.
Boyarsky, Brian J., and Dorry L. Segev. “From Bench to Bill.” Annals of Surgery 263, no. 3 (2016): 
430–33. https://doi.org/10.1097/sla.0000000000001352.
Campos, Pedro, Alberto Ortiz, and Karina Soto. “HIV and Kidney Diseases: 35 Years of History and 
Consequences.” Clinical Kidney Journal 9, no. 6 (2016): 772–81. https://doi.org/10.1093/ckj/
sfw104.
Chan, Cecilia K.y. “Use of Animation in Engaging Teachers and Students in Assessment in Hong 
Kong Higher Education.” Innovations in Education and Teaching International 52, no. 5 (2013): 
474–84. https://doi.org/10.1080/14703297.2013.847795.
Doby, Brianna L., Aaron A.r. Tobian, Dorry L. Segev, and Christine M. Durand. “Moving from the 
HIV Organ Policy Equity Act to HIV Organ Policy Equity in Action.” Current Opinion in Organ 
Transplantation 23, no. 2 (2018): 271–78. https://doi.org/10.1097/mot.0000000000000510.
Durand, Christine M., Dorry Segev, and Jeremy Sugarman. “Realizing HOPE: The Ethics of Organ 
Transplantation From HIV-Positive Donors.” Annals of Internal Medicine 165, no. 2 (May 2016): 
138. https://doi.org/10.7326/m16-0560.
“Find Your Local Organ Procurement Organization.” Health Resources & Services Administration, 
January 16, 2020. https://www.organdonor.gov/awareness/organizations/local-opo.html.
George, Sheba, Erin Moran, Nelida Duran, and Robert A JEnders. “Using Animation as an Informa-
tion Tool to Advance Health Research Literacy among Minority Participants.” AMIA Annual Sym-
posium Proceedings, November 16, 2013, 475–84. https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC3900192/.
HOPE in Action Multicenter Kidney Study. (2019) “HIA Informed Consent Form.”
Ishikawa, Hirono, and Eiji Yano. “Patient Health Literacy and Participation in the Health-Care 
Process.” Health Expectations 11, no. 2 (2008): 113–22. https://doi.org/10.1111/j.1369-
7625.2008.00497.x.
Kurt, Adile Askim. “Personalization Principle in Multimedia Learning: Conversational versus Formal 
75
Style in Written Word.” Turkish Online Journal of Educational Technology - TOJET 10, no. 3 
(July 2011): 185–92.
Mayer, Richard E. Multimedia Learning. Cambridge: Cambridge University Press, 2012.
Mayer, Richard E. The Cambridge Handbook of Multimedia Learning. New York: Cambridge Univer-
sity Press, 2014.
Meppelink, Corine S, Julia Cm Van Weert, Carola J Haven, and Edith G Smit. “The Effectiveness of 
Health Animations in Audiences With Different Health Literacy Levels: An Experimental Study.” 
Journal of Medical Internet Research 17, no. 1 (2015). https://doi.org/10.2196/jmir.3979.
Muzaale, Abimereki D., Allan B. Massie, Mei-Cheng Wang, Robert A. Montgomery, Maureen A. 
Mcbride, Jennifer L. Wainright, and Dorry L. Segev. “Risk of End-Stage Renal Disease Follow-
ing Live Kidney Donation.” JAMA 311, no. 6 (December 2014): 579. https://doi.org/10.1001/
jama.2013.285141.
Nguyen, Anh Q., Saad K. Anjum, Samantha E. Halpern, Komal Kumar, Sarah E. Van Pilsum Rasmus-
sen, Brianna Doby, Ashton A. Shaffer, et al. “Willingness to Donate Organs Among People Living 
With HIV.” JAIDS Journal of Acquired Immune Deficiency Syndromes 79, no. 1 (2018). https://
doi.org/10.1097/qai.0000000000001760.
Nguyen, Tam H., Hyunjeong Park, Hae-Ra Han, Kitty S. Chan, Michael K. Paasche-Orlow, Jolie 
Haun, and Miyong T. Kim. “State of the Science of Health Literacy Measures: Validity Implica-
tions for Minority Populations.” Patient Education and Counseling 98, no. 12 (2015): 1492–1512. 
https://doi.org/10.1016/j.pec.2015.07.013.
Plain Language Thesaurus for Health Communications. Atlanta, GA: National Center for Health 
Marketing, Centers for Disease Control and Prevention, Department of Health & Human Services, 
2007.
Rasmussen, Sarah E. Van Pilsum, Mary Grace Bowring, Ashton A. Shaffer, Macey L. Henderson, 
Allan Massie, Aaron A. R. Tobian, Dorry L. Segev, and Christine M. Durand. “Knowledge, At-
titudes, and Planned Practice of HIV-Positive to HIV-Positive Transplantation in US Transplant 
Centers.” Clinical Transplantation 32, no. 10 (2018). https://doi.org/10.1111/ctr.13365.
Segev, Dorry. “A New Era in HOPE: Living Donation.” Presentation, Expanding HOPE: New Hori-
zons in Transplantation and Donors with Viral Infections from National Institute of Allergy and 
Infectious Diseases, Rockville, MD, December 17, 2019.
Selhorst, Philippe, Catharina E. Combrinck, Kathryn Manning, Francois C.j. Botha, Jan P.l. Labuscha-
gne, Colin Anthony, David L. Matten, et al. “Longer-Term Outcomes of HIV-Positive–to–HIV-
Positive Renal Transplantation.” New England Journal of Medicine 381, no. 14 (March 2019): 
1387–89. https://doi.org/10.1056/nejmc1903013.
Smith, Davey M., Douglas D. Richman, and Susan J. Little. “HIV Superinfection.” The Journal of 
Infectious Diseases 192, no. 3 (2005): 438–44. https://doi.org/10.1086/431682.
“Statistics.” UCSF, 2018. https://pharm.ucsf.edu/kidney/need/statistics.
76
“Statistics Overview.” Centers for Disease Control and Prevention. Centers for Disease Control and 
Prevention, November 21, 2019. https://www.cdc.gov/hiv/statistics/overview/index.html.
Stosor, Valentina. “Organ Transplantation in HIV Patients: Current Status and New Directions.” Cur-
rent Infectious Disease Reports 15, no. 6 (2013): 526–35. https://doi.org/10.1007/s11908-013-
0381-x.
Weiss, Barry D., and Joanne G. Schwartzberg. Health Literacy: a Manual for Clinicians: Part of an 
Educational Program about Health Literacy. Washington, DC: American Medical Association 
Foundation, 2003.




Morgan N. Summerlin was born in Charlotte, North Carolina and raised in Clemson, South 
Carolina. Growing up with an artistic and outdoorsy family and a love for science, she discovered 
the profession of medical and biological illustration in middle school. While also creating 
custom frames and portraits in an art studio she shared with her mother, Morgan continued her 
education at Clemson University with a major in Biological Sciences and a minor in Art. During 
her undergraduate studies, she immersed herself in scientific research and created educational 
illustrations for peer-reviewed publications. Under the guidance of Dr. John Morse, Professor 
Emeritus of Entomology at Clemson University, and with the support of a Research Experience 
for Undergraduates Grant, she created habitus illustrations for the “Atlas of Common Freshwater 
Macroinvertebrates of Eastern North America”, a novel and comprehensive online training tool 
for aquatic insect education and identification.
In August 2018, Morgan matriculated into the Medical and Biological Illustration graduate 
program in the Department of Art as Applied to Medicine at Johns Hopkins University School 
of Medicine. Here she learned to communicate complex scientific information through engaging 
storytelling techniques in a variety of digital and traditional media. During her first year 
of graduate studies, Morgan was awarded the Association of Medical Illustrators Award of 
Excellence for her anatomical plate illustration, “Pathways of the Greater Petrosal Nerve”. In her 
future endeavors, she plans to use her rigorous science and art training to create compelling and 
accurate visual media that instill a better understanding of the scientific world around us. Morgan 
is currently a candidate to receive a Master of Arts in Medical and Biological Illustration in May 
of 2020.
